ReviewFrontiers in oncology2022

Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer.

Izabela Siemińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.